dihexa orally active (PNB-0408) | c-Met/HGFR Activator Strive Dihexa Supplements | Eye

Nose-to-brain delivery of drug nanocrystals by using Ca2+ responsive deacetylated gellan gum based in situ-nanogel

Kawas C, McCoy AM, Yamamoto BK, Wright JW, Harding JW

(European Neurology 1984) reported symptom relief in 97% of opioid withdrawal patients and in 87% of alcohol withdrawal patients

Pericytes also react to cytokines and triggers the release of proinflammatory molecules, which leads to BBB breakdown in vitro and induces activation of a proinflammatory state of astrocytes, endothelial cells, and microglia, the brains innate immune cell [31]

Human Clinical Studies No human clinical trials of Dihexa itself have been conducted or published